Recruiting Risk Factors for Neuroendocrine Neoplasms NCT06282016 Conditions Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more Locations Bavarian Cancer Registry, Bavarian Health and Food Safety Authority — Nuremberg, Bavaria, Germany View Trial Details
Recruiting Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients NCT06523582 Conditions Abnormalities, Multiple, Adenocarcinoma, Adenoma, +103 more Locations Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social — Mexico City, Mexico Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán — Mexico City, Mexico Red de Apoyo a la Investigación, Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México — Mexico City, Mexico View Trial Details
Completed Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin NCT03095274 Conditions Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more Locations Instituto Catalán de Oncología Badalona — Badalona, Barcelona, Spain Complejo Hospitalario de Navarra — Pamplona, Navarre, Spain Hospital Universitario Marqués de Valdecilla — Santander, Principality of Asturias, Spain Hospital Duran i Reynals/ICO L'Hospitalet — Barcelona, Spain View all 19 locations View more locations Show fewer locations Loading locations... View Trial Details
